Oncodesign Precision Medicine SA (ALOPM)
EU
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Assets | 18.37M | 16.63M |
Total Current Assets | 16.41M | 14.4M |
Cash and Equivalents | 13.37M | 322k |
Total Non-Current Assets | 9.84M | 1.75M |
Total Liabilities | 8.53M | 14.88M |
Total Current Liabilities | 4.55M | 5.68M |
Total Non-Current Liabilities | 6.01M | 16.46M |
Total Equity | 9.84M | 1.75M |
Common Equity | 5.68M | 5.7M |
Retained Earnings | -231k | -8.32M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.